Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

BACKGROUND: We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC) patients pre-treated with anthracycline and taxane. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasa, Tsutomu, Tsurutani, Junji, Watanabe, Satomi, Kato, Ryoji, Mizuno, Yutaka, Kojima, Yasuyuki, Takashima, Tsutomu, Matsunami, Nobuki, Morimoto, Takashi, Yamamura, Jun, Ohtani, Shoichiro, Tanabe, Yuko, Yoshinami, Tetsuhiro, Takano, Toshimi, Komoike, Yoshifumi, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796350/
https://www.ncbi.nlm.nih.gov/pubmed/31619197
http://dx.doi.org/10.1186/s12885-019-6200-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796350/
https://www.ncbi.nlm.nih.gov/pubmed/31619197
http://dx.doi.org/10.1186/s12885-019-6200-5

Ejemplares similares